News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
897,899 Results
Type
Article (89665)
Company Profile (614)
Press Release (807596)
Multimedia
Podcasts (283)
Webinars (44)
Section
Business (267504)
Career Advice (4176)
Deals (40158)
Drug Delivery (246)
Drug Development (92143)
Employer Resources (212)
FDA (18737)
Job Trends (17562)
News (399622)
Policy (40038)
Tag
2025 Best Places to Work (23)
2026 Best Places to Work (36)
2027 BioCapital Standard (5)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (13)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Standard (7)
2027 Genetown Digital (6)
2027 Genetown Elite (3)
2027 Genetown Standard (6)
2027 NextGen (20)
2027 Pharm Country Digital (8)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (3112)
Academic (2)
Accelerated approval (76)
ADA (54)
Adcomms (44)
Allergies (237)
Alliances (56999)
ALS (290)
Alzheimer's disease (2140)
Antibody-drug conjugate (ADC) (775)
Approvals (19326)
Artificial intelligence (1144)
ASCO (350)
Autoimmune disease (532)
Automation (84)
Bankruptcy (414)
Belgium (43)
Best Places to Work (12636)
BIO (84)
Biologics (116)
BIOSECURE Act (23)
Biosimilars (306)
BioSpace Insights (270)
Biotechnology (340)
Bispecific (59)
Bladder cancer (252)
Brain cancer (103)
Breast cancer (975)
Cancer (8036)
Cardiovascular disease (681)
Career advice (3638)
Career pathing (65)
CAR-T (464)
CDC (82)
CDMO (235)
Celiac Disease (7)
Cell-line development (2)
Cell therapy (1275)
Cervical cancer (67)
Clinical research (81206)
Collaboration (2880)
Commercialization (75)
Company closure (10)
Compensation (1936)
Complete response letters (128)
COVID-19 (3087)
CRISPR (155)
CRO (7)
C-suite (1708)
Cystic fibrosis (182)
Data (11124)
Decentralized trials (4)
Denatured (112)
Depression (229)
Dermatology (207)
Diabetes (852)
Diagnostics (7942)
Digital health (85)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (564)
Drug pricing (254)
Drug shortages (41)
Duchenne muscular dystrophy (388)
Earnings (104760)
Editorial (85)
Employer branding (27)
Employer resources (184)
ESMO (439)
Events (141946)
Executive appointments (1383)
Eye disease (26)
FDA (23846)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (42)
Funding (2372)
Gene editing (323)
Generative AI (116)
Gene therapy (988)
GLP-1 (1413)
Government (5635)
Grass and pollen (8)
Guidances (446)
Healthcare (21518)
Hematology (235)
HIV (127)
Huntington's disease (93)
Idiopathic pulmonary fibrosis (15)
IgA nephropathy (155)
Immunology and inflammation (431)
Immuno-oncology (166)
Indications (296)
Infectious disease (3549)
Inflammatory bowel disease (285)
Inflation Reduction Act (17)
Influenza (168)
Intellectual property (387)
Interviews (830)
IPO (18071)
IRA (61)
Job creations (5211)
Job search strategy (2882)
JPM (73)
Kidney cancer (31)
Kidney disease (180)
Labor market (152)
Layoffs (733)
Leadership (70)
Legal (10180)
Licensing (126)
Liver cancer (121)
Longevity (58)
Lung cancer (1106)
Lung diease (27)
Lymphoma (565)
Machine learning (78)
Management (72)
Manufacturing (1656)
Marketing (41)
MASH (260)
Medical affairs (5)
Medical device (15483)
Medtech (15819)
Mergers & acquisitions (23642)
Metabolic disorders (2163)
Middle East (2)
mRNA (344)
Multiple sclerosis (261)
Multispecific (6)
NASH (24)
Netherlands (39)
Neurodegenerative disease (634)
Neuropsychiatric disorders (155)
Neuroscience (4349)
Neurotech (4)
NextGen: Class of 2026 (7718)
Non-profit (5175)
Now hiring (101)
Obesity (1019)
Opinion (410)
Ovarian cancer (300)
Pain (352)
Pancreatic cancer (458)
Parkinson's disease (495)
Partnered (53)
Patents (814)
Patient advocacy (8)
Patient recruitment (988)
Patient selection (117)
Peanut (81)
People (69151)
Peptides (43)
Pharmaceutical (83)
Pharmacy benefit managers (43)
Phase 1 (25045)
Phase 2 (35272)
Phase 3 (26588)
Pipeline (14577)
Policy (434)
Postmarket research (3561)
Preclinical (11203)
Press Release (74)
Prostate cancer (412)
Psychedelics (103)
Radioligand (3)
Radiopharmaceuticals (448)
Rare diseases (1613)
Real estate (7479)
Recruiting (84)
Regenerative medicine (38)
Regulatory (31876)
Reports (104)
Research institute (2823)
Resumes & cover letters (657)
Rett syndrome (59)
RNA editing (39)
RSV (107)
Saudi Arabia (1)
Schizophrenia (229)
Series A (409)
Series B (284)
Service/supplier (16)
Sickle cell disease (152)
Special edition (38)
Spinal muscular atrophy (201)
Sponsored (61)
Startups (4404)
State (2)
Stem cells (8)
Stomach cancer (24)
Substance use disorders (23)
Supply chain (172)
Switzerland (21)
Tariffs (108)
Tax incentives (2)
The Weekly (168)
Vaccines (1447)
Venture capital (184)
Weight loss (680)
Wet AMD (7)
Women's health (190)
Women in leadership (1)
Worklife (28)
Date
Today (64)
Last 7 days (961)
Last 30 days (3770)
Last 365 days (33862)
2026 (30528)
2025 (33214)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51334)
2018 (39119)
2017 (37186)
2016 (38329)
2015 (44431)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1310)
Alabama (118)
Alaska (7)
Arizona (491)
Arkansas (17)
Asia (53196)
Australia (9369)
California (17325)
Canada (4763)
China (2066)
Colorado (769)
Connecticut (774)
Delaware (543)
Europe (122826)
Florida (2626)
Georgia (565)
Hawaii (5)
Idaho (70)
Illinois (1501)
India (155)
Indiana (785)
Iowa (37)
Japan (779)
Kansas (159)
Kentucky (69)
Louisiana (72)
Maine (99)
Maryland (2045)
Massachusetts (12538)
Michigan (475)
Minnesota (953)
Mississippi (8)
Missouri (189)
Montana (38)
Nebraska (31)
Nevada (203)
New Hampshire (94)
New Jersey (4587)
New Mexico (38)
New York (4515)
North Carolina (2249)
North Dakota (14)
Northern California (8851)
Ohio (542)
Oklahoma (32)
Oregon (55)
Pennsylvania (3318)
Puerto Rico (38)
Rhode Island (66)
South America (1674)
South Carolina (104)
South Dakota (2)
Southern California (6898)
Tennessee (285)
Texas (2878)
United States (61418)
Utah (526)
Vermont (2)
Virginia (436)
Washington D.C. (89)
Washington State (1383)
West Virginia (4)
Wisconsin (200)
Wyoming (6)
897,899 Results for "zealand pharma a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Weight loss
Despite Zealand asset’s ‘intriguing’ weight loss, analysts underwhelmed by blood sugar numbers
For the second time in a week, Zealand Pharma’s weight loss pipeline has delivered mixed results, this time in a Phase 2 trial for the Roche-partnered asset petrelintide.
October 8, 2026
·
4 min read
·
Annalee Armstrong
Obesity
Boehringer, Zealand’s obesity drug doesn’t elevate heart risk in key late-stage test
The Phase 3 results help clarify the safety profile of Zealand and Boehringer Ingelheim’s survodutide, but analysts do not think the drug will find utility beyond patients with liver-related risk factors.
November 9, 2026
·
4 min read
·
Annalee Armstrong
Obesity
Zealand pens up to $1.2B deal with Generate for AI-designed obesity, metabolic drugs
Obesity-focused Zealand Pharma is buying into Generate:Biomedicines’s generative AI platform to create new multispecific drug candidates.
October 14, 2026
·
3 min read
·
Tristan Manalac
Rare diseases
Zealand sells milestone, royalty rights to rare blood cancer asset for up to $100M
The terms of the agreement with Royalty Pharma suggest the market potential of Zealand Pharma’s polycythemia vera drug candidate may be undervalued, according to Jefferies analysts.
August 13, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Zealand Pharma to participate in the 2026 Jefferies Global Healthcare Conference
November 10, 2026
·
1 min read
Obesity
Zealand dips as Boehringer Ingelheim-partnered weight loss drug fails to impress—again
Despite meeting the primary endpoints in a Phase 3 trial, shares of Zealand Pharma dropped in premarket trading Thursday as the up to 9.8% weight loss reflected inferior loss to that generated by competitors.
October 1, 2026
·
2 min read
·
Heather McKenzie
Obesity
Boehringer, Zealand’s obesity drug ‘more akin’ to Novo’s Wegovy in Phase 3
Topline Phase 3 results of survodutide—licensed to Boehringer Ingelheim from Zealand Pharma—are more comparable to Novo Nordisk’s Wegovy than to Eli Lilly’s Zepbound, William Blair analysts said on Tuesday.
April 28, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Zealand Pharma Announces Financial Results for the First Nine Months of 2026
November 12, 2026
·
12 min read
Weight loss
Roche, Zealand’s Amylin Weight Loss Drug Fails To Clear Lilly’s Bar
Zealand Pharma’s shares fell 32% in early morning trading Friday after its Roche-partnered asset petrelintide failed to meet investor expectations in a mid-stage clinical trial.
March 6, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
November 15, 2026
·
10 min read
1 of 89,790
Next